SCHEMBL8289201

SCHEMBL8289201

N[C@H](CS)C(=O)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29581937 1.00
SCHEMBL456395 0.80 PTGS1 (0.55)
SCHEMBL28547750 0.80 PTGS1 (0.55)
Cysteine SCHEMBL6192962 0.78 PTGS1 (0.84)
SCHEMBL2941639 0.74 PTGS1 (0.55)
SCHEMBL2941633 0.74 PTGS1 (0.55)
Cysteine SCHEMBL7898895 0.73 PTGS1 (1.00)
Cysteine SCHEMBL5705430 0.73 PTGS1 (1.00)
Cysteine SCHEMBL4289403 0.73
Cysteine SCHEMBL21110883 0.73 PTGS1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005042027-A2 ANTAGONISTS OF THE BRADYKININ B1 RECEPTOR AMGEN INC. (US) 2005-05-12 WO disclosed